N@N

Nicole Gabreski Maintained (TVTX) at Hold with Decreased Target to $10 on, Oct 25th, 2023

Nicole Gabreski of Piper Sandler, Maintained "Travere Therapeutics, Inc." (TVTX) at Hold with Decreased Target from $19 to $10 on, Oct 25th, 2023.

Nicole has made no other calls on TVTX in the last 4 months.

There are 10 other peers that have a rating on TVTX. Out of the 10 peers that are also analyzing TVTX, 2 agree with Nicole's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Mohit Bansal of "Wells Fargo" Downgraded from Buy to Hold and Decreased Target to $8 on, Friday, September 22nd, 2023
• Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Thursday, September 21st, 2023

These are the ratings of the 8 analyists that currently disagree with Nicole

---

• Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $12 on, Friday, September 29th, 2023
• Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $14 on, Friday, September 22nd, 2023
• Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $12 on, Friday, September 22nd, 2023
• Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
• Greg Harrison of "B of A Securities" Maintained at Strong Buy with Decreased Target to $27 on, Friday, September 22nd, 2023
• Vamil Divan of "Guggenheim" Maintained at Strong Buy with Decreased Target to $18 on, Friday, September 22nd, 2023
• Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $26 on, Friday, July 21st, 2023
• Edward Nash of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $35 on, Tuesday, July 18th, 2023

Contributing Sources

---